Lifecore Biomedical, Inc. LFCR

LFCR Company Overview

Lifecore Biomedical, Inc. (NASDAQ: LFCR) is a U.S.-based contract development and manufacturing organization (CDMO) focused on the production of sterile injectable pharmaceutical products and medical-grade biomaterials. The company operates primarily within the pharmaceutical manufacturing, biotechnology, and medical technology industries, with a specialization in highly regulated injectable formulations and hyaluronic acid–based products. Lifecore’s core revenue drivers include contract manufacturing services for pharmaceutical and biotechnology customers, formulation development, aseptic filling, and the production of pharmaceutical-grade sodium hyaluronate used in ophthalmic, orthopedic, and aesthetic medical applications.

The company traces its origins to agricultural and food-related businesses historically associated with Land O’Lakes and later Apogee Enterprises before evolving into a life sciences and medical manufacturing company. Over time, Lifecore shifted its strategic focus toward biopharmaceutical manufacturing and specialty biomaterials, ultimately positioning itself as a specialized CDMO with expertise in sterile injectables and complex biologics support. Its strategic differentiation is tied to integrated capabilities in process development, aseptic manufacturing, regulatory compliance, and long-standing expertise in high-purity hyaluronic acid technologies.